Hong T. Wang
Collaborative Innovation Center Of Yangtze River Delta Region Green Pharmaceuticals
Hangzhou, 310014, China
Hangzhou, 310014, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Molecular Construction and Anti-Bladder Cancer Study of Novel TOP1/PARP1 Dual-Target Inhibitors.
Journal: Journal of medicinal chemistry
Published: July 27, 2026
Gut Bacterial β-Glucuronidase Blockade by 1,3,4-Thiadiazole-Containing Thioester Inhibitors Mitigates Irinotecan-Induced Gastrointestinal Toxicity.
Journal: Journal of medicinal chemistry
Published: July 23, 2026
Soluplus®-based solid dispersion enhances oral bioavailability of A10: a cGAS-STING and ICD activator for bladder cancer therapy.
Journal: International journal of pharmaceutics
Published: March 08, 2026
Pharmacological activities, SARs and targets of heterocyclic derivatives as QSIs against bacteria multidrug resistance.
Journal: European journal of medicinal chemistry
Published: February 26, 2026
Design and Synthesis of Novel Dual Fluoro-Substituted 10,11-Methylenedioxy-pyrrolo[3,4-b]quinoline Alkaloid Analogs as Topo I/DDX5 Inhibitors for Colorectal Cancer.
Journal: Journal of medicinal chemistry
Published: January 02, 2026
Exploring the Biosynthetic Potential of Microorganisms from the South China Sea Cold Seep Using Culture-Dependent and Culture-Independent Approaches.
Journal: Marine drugs
Published: July 11, 2025
Phylogenomics-driven metalloantibiotic engineering: Overcoming ciprofloxacin resistance in Pseudomonasaeruginosa with sideromycin-bismuth synergy.
Journal: Cell reports. Medicine
Published: July 08, 2025
Last Updated: 09/26/2026